Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Selecky Christobel
Over the trailing 90 days, Selecky Christobel (Director at ImmunityBio, Inc.) traded $3.1M of stock (net selling $1.5M) in IBRX, per 18 SEC Form 4 transactions.
- Role
- Director
- Companies
- IBRX
- Window
- Trailing 90 days · 18 transactions · CIK 1849739
- Net activity
- −$1.5M ($761K bought · $2.3M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | 18 | $761K | $2.3M | −$1.5M |
Transactions (18)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-01 | IBRX | Sell | 35.1K | $0 | Exercise or conversion of derivative security |
| 2026-07-01 | IBRX | Sell | 124.4K | $0 | Exercise or conversion of derivative security |
| 2026-07-01 | IBRX | Buy | 124.4K | $372K | Exercise or conversion of derivative security |
| 2026-07-01 | IBRX | Buy | 35.1K | $104K | Exercise or conversion of derivative security |
| 2026-07-01 | IBRX | Sell | 159.5K | $1.4M | Open market or private sale |
| 2026-06-30 | IBRX | Sell | 1.0K | $9K | Open market or private sale |
| 2026-06-30 | IBRX | Buy | 700 | $2K | Exercise or conversion of derivative security |
| 2026-06-30 | IBRX | Buy | 300 | $897 | Exercise or conversion of derivative security |
| 2026-06-30 | IBRX | Sell | 700 | $0 | Exercise or conversion of derivative security |
| 2026-06-30 | IBRX | Sell | 300 | $0 | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Buy | 30.0K | $85K | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Buy | 33.5K | $100K | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Buy | 32.2K | $96K | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Sell | 95.7K | $862K | Open market or private sale |
| 2026-06-29 | IBRX | Sell | 30.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Sell | 32.2K | $0 | Exercise or conversion of derivative security |
| 2026-06-29 | IBRX | Sell | 33.5K | $0 | Exercise or conversion of derivative security |
| 2026-06-09 | IBRX | Buy | 65.6K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Selecky's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.